Skip to main content
SpringerLink
Log in

Chemoprevention by Curcumin

  • Chapter
  • First Online:
Cancer and Chemoprevention: An Overview

  • 668 Accesses

Abstract

Curcumin (diferuloylmethane or 1, 7-bis-(4-hydroxy-3-methoxylphenyl)-1, 6-heptadiene-3, 5-dione), a phenolic compound and a yellow spice, is the active ingredient of the turmeric spice from the plant Curcuma longa which has been used for thousands of years in traditional medicine for various ailments like inflammatory diseases in Asia. Not only is this used in treating inflammatory diseases, but it is also being used extensively for centuries in cooking. In Ayurveda, Unani, and Siddha medicine, turmeric powder is used as a home remedy for various diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85–94

    Article  CAS  PubMed  Google Scholar 

  • Al-Hujaily EM, Mohamed AG, Al-Sharif I et al (2011) PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells. Breast Cancer Res Treat 128:97–107

    Article  CAS  PubMed  Google Scholar 

  • Arbiser JL, Klauber N, Rohan R et al (1998) Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4:376–383

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bao B, Ali S, Banerjee S et al (2012) Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res 72:335–345

    Article  CAS  PubMed  Google Scholar 

  • Basnet P, Skalko-Basnet N (2011) Curcumin. an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16:4567–4598

    Article  CAS  PubMed  Google Scholar 

  • Berlowitz L, Pallotta D (1972) Acetylation of nuclear protein in the heterochromatin and euchromatin of mealy bugs. Exp Cell Res 71:45–48

    Article  CAS  PubMed  Google Scholar 

  • Boyanapalli SS, Tony KAN (2015) Curcumin, the King of Spices. Epigenetic Regulatory Mechanisms in the Prevention of Cancer, Neurological, and Inflammatory Diseases. Curr Pharmacol Rep 1:129–139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cai XZ, Wang J, Li XD et al (2009) Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 8:1360–1368

    Article  CAS  PubMed  Google Scholar 

  • Casey SC, Amedei A, Aquilano K et al (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol 35:S199–S223

    Article  PubMed  PubMed Central  Google Scholar 

  • Chang LC, Yu YL (2016) Dietary components as epigenetic-regulating agents against cancer. Biomedicine (Taipei) 6:2

    Article  Google Scholar 

  • Chen CQ, Yu K, Yan QX et al (2013) Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. Carcinogenesis 34:1442–1449

    Article  CAS  PubMed  Google Scholar 

  • Choudhuri S, Cui Y, Klaassen CD (2010) Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 245:378–393

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chung MY, Lim TG, Lee KW (2013) Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol 19:984–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De R, Kundu P, Swarnakar S et al (2009) Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother 53:1592–1597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feitelson MA, Arzumanyan A, Kulathinal RJ et al (2015) Sustained proliferation in cancer. Mechanisms and novel therapeutic targets. Semin Cancer Biol 35(Suppl):S25–S54

    Article  PubMed  PubMed Central  Google Scholar 

  • Gupta A, Zhou CQ, Chellaiah MA (2013) Osteopontin and MMP9 association with VEGF expression/secretion and angiogenesis in PC3 prostate cancer cells. Cancers (Basel) 5:617–638

    Article  CAS  Google Scholar 

  • Hartojo W, Silvers AL, Thomas DG et al (2010) Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 3:99–108

    Article  PubMed  PubMed Central  Google Scholar 

  • Kuipers EJ (1999) Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 13:3–11

    Article  PubMed  Google Scholar 

  • Kuno T, Tsukamoto T, Hara A et al (2012) Cancer chemoprevention through the induction of apoptosis by natural compounds. J Biophys Chem 3:156–173

    Article  CAS  Google Scholar 

  • Liao S, Xia J, Chen Z et al (2011) Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways. J Cell Biochem 112:1055–1065

    Article  CAS  PubMed  Google Scholar 

  • Lin YG, Kunnumakkara AB, Nair A et al (2007) Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13:3423–3430

    Article  CAS  PubMed  Google Scholar 

  • Liu Z, Xie Z, Jones W et al (2009) Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 19:706–709

    Article  PubMed  Google Scholar 

  • Mendelson J, Song S, Li Y et al (2011) Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett’s esophageal adenocarcinoma. Cancer 117:3691–3702

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nephew KP, Huang TH (2003) Epigenetic gene silencing in cancer initiation and progression. Cancer Lett 190:125–133

    Article  CAS  PubMed  Google Scholar 

  • Purkayastha S, Berliner A, Fernando SS et al (2009) Curcumin Blocks Brain Tumor Formation. Brain Res 1266:130–138

    Article  CAS  PubMed  Google Scholar 

  • Rayet B, Gélinas C (1999) Aberrant rel/NFkB genes and activity in human cancer. Oncogene 18:6938–6947

    Article  CAS  PubMed  Google Scholar 

  • Shu L, Khor TO, Lee JH et al (2011) Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13:606–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Subramaniam D, May R, Sureban SM (2008) Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res 68:1962–1969

    Article  CAS  PubMed  Google Scholar 

  • Wang D, Veena MS, Stevenson K et al (2008) Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14:6228–6236

    Article  CAS  PubMed  Google Scholar 

  • Wang Z, Dabrosin C, Yin X et al (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S224–S243

    Article  PubMed  PubMed Central  Google Scholar 

  • Wilken R, Veena MS, Wang MB et al (2011) Curcumin: a review of anticancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer 10:12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yamazaki K, Gohda J, Kanayama A et al (2009) Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal 2:ra66

    Article  PubMed  Google Scholar 

  • Yan G, Graham K, Lanza-Jacoby S (2013) Curcumin enhances the anticancer effects of trichostatin A in breast cancer cells. Mol Carcinog 52:404–411

    Article  CAS  PubMed  Google Scholar 

  • Yang J, Cao Y, Sun J et al (2010) Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells. Med Oncol 27:1114–1118

    Article  CAS  PubMed  Google Scholar 

  • Yoysungnoen P, Wirachwong P, Bhattarakosol P et al (2006) Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34:109–115

    CAS  PubMed  Google Scholar 

  • Yu LL, Wu JG, Dai N et al (2011) Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep 26:1197–1203

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Toxicology, Jamia Hamdard, New Delhi, India

    Summya Rashid

Authors
  1. Summya Rashid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Rashid, S. (2017). Chemoprevention by Curcumin. In: Cancer and Chemoprevention: An Overview. Springer, Singapore. https://doi.org/10.1007/978-981-10-2579-2_19

Download citation

Publish with us

Policies and ethics

Search

Navigation